Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
AURLUMYN (ILOPROST) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
AURLUMYN
NDA
Get alerts
ILOPROST | N217933 | BTG INTERNATIONAL INC
1 strength
2 unique patents
2 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
2 unique patents, 2 exclusivities by expiration date
Active (2)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
Today
12409183
Jul. 18, 2044
12409184
Aug. 6, 2041
NP
Feb. 13, 2027
ODE-465
Feb. 13, 2031
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 100MCG/ML (100MCG/ML)
RLD
2 patents
2 exclusivities
▴
SOLUTION;INTRAVENOUS | Approved: Feb 13, 2024
Patents (2)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
12409183
Jul 18, 2044
—
—
—
U-4263
TREATMENT OF SEVERE FROSTBITE IN ADULTS TO REDUCE THE RISK OF DIGIT AMPUTATIONS
—
12409184
Aug 6, 2041
—
—
Yes
—
—
Exclusivities (2)
Code
Date
Status
NP
Feb 13, 2027
< 1 year
ODE-465
Feb 13, 2031
Active